CHRS Stock Forecast & Price Target
CHRS Stock
Price Forecast
The average stock forecast for
Coherus BioSciences Inc (CHRS) in the next 12 months is 7.14 USD. This price target corresponds to an upside
of
421.17%. The range of stock forecasts for CHRS is 4.04 - 10.50 USD.
Based on the ratings of 12 analysts, the consensus recommendation for CHRS is
BUY.
| Target |
Low |
Average |
Median |
High |
| Price (USD) |
4.04 |
7.14 |
7.14 |
10.50 |
| Upside |
194.89% |
421.17% |
421.17% |
666.42% |
Recommendation Trends
The latest consensus rating for CHRS is "BUY". This is the average
recommendation of 12 analysts: 0 strong sell,
0 sell, 2 hold, 6 buy, 4 strong buy. In the previous period, 13 analysts also majorly recommmended
"BUY" for CHRS.
CHRS Financial Stock
Forecast
Revenue This Year
from 42.17M
Revenue Next Year
from 61.03M